For the quarter ended March 2026, Infosys (INFY) reported revenue of $5.04 billion, up 6.6% over the same period last year. EPS came in at $0.23, compared to $0.20 in the year-ago quarter.
The reported revenue represents a surprise of +0.49% over the Zacks Consensus Estimate of $5.02 billion. With the consensus EPS estimate being $0.20, the EPS surprise was +12.75%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Infosys performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Employee Metrics - S/W professionals: 310,887 versus 253,221 estimated by two analysts on average. Utilization - Including trainees - Consolidated: 79.7% versus the two-analyst average estimate of 81.5%. Utilization - Excluding trainees - Consolidated: 83% versus 84.6% estimated by two analysts on average. Employee Metrics - Sales & Support: 17,707 versus 14,074 estimated by two analysts on average.View all Key Company Metrics for Infosys here>>>
Shares of Infosys have returned +2.4% over the past month versus the Zacks S&P 500 composite's +9.7% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
American Noble Gas Inc. (INFY): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).